Daewoong Pharmaceutical Co. LTD.: Hypertension trials

The registry lists 16 Hypertension studies with Daewoong Pharmaceutical Co. LTD. as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 1 3Phase 3 6Phase 4 1No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Observational Study to Evaluate the Efficacy of OLMETEC Tab on Nocturnal Blood Pressure Control in Patients With Stage Ⅰ HypertensionRecruitingNCT07515599
• Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or DyslipidemiaRecruitingNCT06647888
• Efficacy and Safety of DWC202404 and DWC202314 in Patients With HypertensionCompletedNCT06682000Phase 3
• Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With DyslipidemiaActive, not recruitingNCT05660135
• A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Concomitant Hypertension and HyperlipidemiaCompletedNCT05643508Phase 3
• Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar TabActive, not recruitingNCT05411887
• Observational Study to Evaluate the Therapeutic Effectiveness and Safety of Olomax TabCompletedNCT05184179
• Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451Status unknownNCT04161001Phase 3
• Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX TabCompletedNCT04120753Phase 4
• Observational Study to Investigate the Effectiveness and Safety of Olostar Tab in Patients With Essential Hypertension and DyslipidemiaStatus unknownNCT03009721
• A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and HyperlipidemiaCompletedNCT03009487Phase 3
• Bioequivalence Study (Candesartan 16 mg and Amlodipine 10 mg)CompletedNCT02988362Phase 1
• Pharmacokinetic Interactions and Safety Study of Telmisartan and ChlorthalidoneCompletedNCT01806363Phase 1
• Safety and Pharmacokinetics Study of amlodipine10mg and candesartan32mgCompletedNCT01806311Phase 1
• Clinical Study for Patients With Hypertension Associated With DyslipidemiaCompletedNCT01764295Phase 3
• Efficacy and Safety of HL-040XC in Essential Hypertension and HyperlipidemiaCompletedNCT01541943Phase 3